X
Sunday, May 11, 2025
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Europe

International Law Enforcement Action Against Fake Medicines

Yuvraj_pawp by Yuvraj_pawp
2nd September 2014
in Europe, Facilities & Operation

Law enforcement authorities from Austria, Belgium, Cyprus, France, Hungary, Slovakia, Spain and the United Kingdom, supported by Europol and Eurojust, today contributed to simultaneous operations to stop the distribution of prescription-only counterfeit medicines in the European Union.

Today’s operations resulted in seizures of several million pills with an estimated value well in excess of EUR 10 million, a large amount of cash and several vehicles, including luxury models, and the freezing of more than EUR 7.5 million in bank accounts and assets. In addition, 12 suspects were arrested.

The law enforcement activities aimed to specifically counter the activities of the organised crime group (OCG) behind the supply and online distribution of counterfeit medicines – mainly erectile dysfunction pills – and their money laundering activities.

Following intelligence gathered during a criminal pharma case by the authorities in Spain that provided Europol with useful leads and that also assisted further investigations in Austria, France and the UK, several operational meetings were held to inform and exchange information with the concerned Member States and other involved countries. Eurojust organised a coordination meeting to discuss a common strategy among the authorities involved, including the establishment of a joint investigation team (JIT) among Spain, Austria, France and the UK and supported by the authorities in Cyprus, Hungary, and Slovakia, and common action days. Members of the JIT will now travel to other involved countries to facilitate the exchange of information.

Since the beginning of the investigation in September 2012, more than 300 000 pills with an estimated value of EUR 2 million have been seized in Austria alone. However, it is thought that this represents only one-fifth of the total transactions made by the OCG in Austria. In France, payments totalling EUR 9 million were identified as having been processed over three years. In Spain, counterfeit goods worth more than EUR 1.5 million have been seized and three people arrested. Over the last two years, the UK authorities have identified more than EUR 12 million in transactions involving counterfeit and unlicensed medicines. The Hungarian authorities were involved in a similar operation last year.

These latest operations were coordinated from Eurojust premises in The Hague. This facilitated the swift exchange of information, resolution of legal issues and the elaboration of a final overview of the results, tailor-made for the needs of the involved judicial authorities. At the same time, Europol provided valuable assistance by deploying a mobile office for real-time analysis and cross-checking of data on the spot. Simultaneously, experts and analysts from Europol assisted the police and provided forensic and analytical support during the action day.

The counterfeit medicines targeted by this operation are imported into the European Union from Asia and contain incorrect dosages and ingredients which pose a serious health hazard.

Previous Post

Senesco completes patient enrolment in Phase Ib/IIa SNS01-T trial

Next Post

Gilenya® data at ACTRIMS-ECTRIMS to show Novartis is redefining MS treatment goals for patients

Related Posts

Facilities & Operation

Robust Supply Chains Are Essential For Affordable Drugs

18th May 2024
Essential Elements of Quality Management In Lab Practices
Facilities & Operation

8 Essential Elements of Quality Management In Lab Practices

18th May 2024
Facilities & Operation

FDA Solidifies Its Authority Over Laboratory-Developed Tests

18th May 2024
Facilities & Operation

100% Renewable Electricity Record Hit By Charles River Labs

17th May 2024
Facilities & Operation

All Infinity Laboratories Locations Are Now ISO-Accredited

17th May 2024
FDA Solidifies Its Authority Over Laboratory-Developed Tests
Facilities & Operation

Apt Teamwork Holds Key To Successful Lab Design Projects

15th May 2024
Next Post

ABBOTT RECEIVES CE MARK FOR FREESTYLE® LIBRE, A REVOLUTIONARY GLUCOSE MONITORING SYSTEM FOR PEOPLE WITH DIABETES

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Notifications